Insights+: COVID-19 Healthcare News Monthly Updates - October 2020
- Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
- The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019
- PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date
Prenetics Acquires Oxsed, Oxford University Spin-out to Scale Rapid COVID-19 Test Globally. Rapid Airport Testing has begun in Heathrow with Trials in Hong Kong International Airport.
Oct 30, 2020 | Collaboration
OncoSec Announces FDA Clearance of IND Application for Initiation of Phase 1 Clinical Trial of its CORVax12 Vaccine Candidate for COVID-19
Oct 29, 2020 | Regulatory
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
Oct 29, 2020 | Collaboration
Kintor Pharmaceutical's COVID-19 Clinical Trials for Proxalutamide to expand Patient Enrolment
Oct 29, 2020 | Clinical Trial
Data for Lilly's bamlanivimab (LY-CoV555) in COVID-19 outpatients published in New England Journal of Medicine
Oct 28, 2020 | Clinical Trial
Regeneron's COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus Levels and Need for Further Medical Attention
Oct 28, 2020 | Clinical Trial
COVID-19 Immune Response Study Could Lead to More Effective Treatments
Oct 28, 2020 | Clinical Trial
JadiCell Stem Cells Licensed by Therapeutic Solutions International for Brain Injury Significantly Increased Survival of COVID-19 Patients in Double Blind FDA Clinical Trial
Oct 28, 2020 | Collaboration
Daewoong Pharmaceutical's COVID-19 Treatment Candidate Also Highly Effective against Influenza Virus
Oct 28, 2020 | Clinical Trial
Qualigen Therapeutics Receives Positive Pre-IND Response from FDA for the Clinical Development of AS1411 as a Treatment for COVID-19
Oct 28, 2020 | Regulatory
Ampio Begins Phase 1 Clinical Trial of Inhaled Ampion For COVID-19 Patients With Respiratory Distress
Oct 28, 2020 | Regulatory
Daewoong Pharmaceutical's Long-Acting Niclosamide Shows High Promise Against Upcoming COVID-19 'Twindemic'
Oct 27, 2020 | Clinical Trial
Quest Diagnostics and Catapult Health Provide Virtual Preventive Care Services for Employers During COVID-19 Pandemic and Beyond
Oct 27, 2020 | Pharma
Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities
Oct 26, 2020 | Clinical Trial
Clinical Study Begins for the First Oral Systemic Nitric Oxide Based Therapeutic for African Americans with COVID-19
Oct 26, 2020 | Clinical Trial
Truvian Sciences Announces Plans to Make Rapid Antibody Testing More Accessible with Easy Check COVID-19 IgM/IgG POC Antibody Test
Oct 26, 2020 | Diagnostics
Helix Receives Expanded Emergency Use Authorization for On-site Unsupervised Self-Collection and Asymptomatic Screening with the Helix® COVID-19 Test
Oct 26, 2020 | Regulatory
SQI Diagnostics Updates Clinical Progress on Novel COVID-19 Tests Under Development for U.S. FDA Regulatory Submission
Oct 26, 2020 | Regulatory
Biophytis Enrolls First Patient in Brazil in COVA, a Multinational Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure
Oct 26, 2020 | Clinical Trial
Entos Pharmaceuticals Awarded funding to Conduct Phase I Clinical Trial of COVID-19 DNA Vaccine
Oct 23, 2020 | Grant
FDA Approves First Treatment for COVID-19
Oct 22, 2020 | Regulatory
Arizona Based Biotech Company Finds Preliminary Success Developing an Intranasal COVID-19 Vaccine Alternative
Oct 22, 2020 | Clinical Trial
TrippBio Announces the Completion of Enrollment in a Proof of Concept Clinical Trial Evaluating the Efficacy of TD213 in Treating Patients with Confirmed COVID-19 Infections
Oct 22, 2020 | Clinical Trial
Fresenius Medical Care North America Presents New Insights Related to COVID-19 and Dialysis Innovations at Kidney Week 2020
Oct 22, 2020 | Clinical Trial
Alight and THINKMD Rapidly Adapt Established Medical Infrastructure in Fight Against COVID-19
Oct 22, 2020 | Collaboration
Kedrion's Partner, Kamada Ltd, Signs a Supply Agreement with the Israeli Health Authorities for the Investigational Anti-COVID-19 Plasma-Derived Therapy
Oct 22, 2020 | Collaboration
Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine
Oct 22, 2020 | Collaboration
COVID-19 Respiratory Monitoring with MediPines AGM100 in Long-Term Care Facilities
Oct 22, 2020 | Collaboration
Poseida Therapeutics and TScan Therapeutics Announce Research Collaboration and License Agreement to Explore Developing Allogeneic T Cell Receptor Therapies for the Treatment of COVID-19
Oct 21, 2020 | Collaboration
Facilitating the 'Vaccine Era' of COVID-19 Response: ThermoGenesis to Receive U.S. Patent for Breakthrough Serological Test Reader Technology
Oct 20, 2020 | Regulatory
OPKO Health's BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test
Oct 20, 2020 | Launch
IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Phase 2 Clinical Trial
Oct 20, 2020 | Clinical Trial
EIB Provides Immunic With up to '24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy
Oct 20, 2020 | Grant
NHS Hospitals trial ground-breaking new decontamination technology to reduce COVID-19 transmission indoors
Oct 20, 2020 | Clinical Trial
Open Orphan/hVIVO Signs Contract with UK Government for the Development of a COVID-19 Human Challenge Study Model
Oct 20, 2020 | Collaboration
Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients
Oct 19, 2020 | Clinical Trial
Thermo Fisher Scientific Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell
Oct 19, 2020 | Diagnostics
DxTerity Announces a New At-Home COVID-19 Testing Solution
Oct 19, 2020 | Diagnostics
Aetion Statement on UCSF-Led Study to Inform Drug Development for COVID-19, Future Pandemics
Oct 15, 2020 | Clinical Trial
Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test
Oct 15, 2020 | Diagnostics
Beckman Coulter receives BARDA funding to validate Monocyte Distribution Width in the rapid detection of Multisystem Inflammatory Syndrome (MIS-C), a severe COVID-19 complication in Children
Oct 15, 2020 | Diagnostics
Eiger BioPharmaceuticals Announces Positive Results of Investigator Sponsored Randomized Controlled Trial at University of Toronto with Peginterferon Lambda in Outpatients with Mild to Moderate COVID-19
Oct 15, 2020 | Clinical Trial
No Aborted Fetal Material in AVM Biotechnology's COVID-19 Treatment Drug
Oct 14, 2020 | Clinical Trial
New blood test predicts which Covid-19 patients will develop severe infection
Oct 14, 2020 | Diagnostics
Novellus Therapeutics Exclusively Licenses Induced Mesenchymal Stem Cells (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) and Other Acute Respiratory Conditions
Oct 13, 2020 | Collaboration
Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 Adjuvant Receives Taiwan Government Subsidy with First Participant Dosed in Early October
Oct 13, 2020 | Clinical Trial
NeuroRx and Relief announce topline efficacy data from patients treated with RLF-100' (aviptadil) under the U.S. FDA Expanded Access Protocol authorization for respiratory failure related to critical COVID-19
Oct 13, 2020 | Clinical Trial
University of Milan Study Finds Self-Contained, Rapid ADEXUSDx COVID-19 Antibody Test has 100% Specificity
Oct 12, 2020 | Diagnostics
Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test
Oct 12, 2020 | Regulatory
Review Article, Authored by ZyVersa Therapeutics' Esteemed Scientific Advisors, Demonstrates the Role of Inflammasomes in the Exacerbated Immune Response Associated with COVID-19 Infection
Oct 12, 2020 | Clinical Trial
The Covid-19 pandemic is expected to further affect RhoVac's clinical phase IIb study
Oct 12, 2020 | Clinical Trial
Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova
Oct 9, 2020 | Collaboration
Grifols anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19
Oct 9, 2020 | Clinical Trial
Exogenesis Surgical Mask Reaches Primary Endpoints in COVID-19 Deactivation Challenge Trials
Oct 9, 2020 | Clinical Trial
First Patient Enrolled in NIH Phase 3 Trial to Evaluate Potential COVID-19 Hyperimmune Medicine
Oct 8, 2020 | Clinical Trial
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
Oct 8, 2020 | Clinical Trial
Johnson & Johnson Receives European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate
Oct 8, 2020 | Collaboration
Prevea Health Selects Syntellis as Financial Planning Partner to Navigate COVID-19 Market Volatility
Oct 7, 2020 | Collaboration
Abbott Reports Results of ID NOW COVID-19 Interim Clinical Study from 1,003 People to Provide the Facts on Clinical Performance and to Support Public Health
Oct 7, 2020 | Clinical Trial
Centaur Biopharmaceutical Signs Expansion Agreement with Vaxart of Manufacturing for COVID-19 and Other Vaccine Candidates
Oct 7, 2020 | Collaboration
Promising Research Showing New Way To Treat And Stop The Spread Of COVID-19 Using Gene Silencing And Reactivation Of 'Innate' Immune System
Oct 6, 2020 | Clinical Trial
Karyopharm Presents Results of Selinexor at the International Society for Influenza and Other Respiratory Virus Diseases Antiviral Group Virtual Conference on Therapeutics for COVID-19
Oct 6, 2020 | Clinical Trial
CLEAR Collaborates with Quest Diagnostics to Integrate COVID-19 Test Results with 'Health Pass' for Safer Environments
Oct 5, 2020 | Collaboration
Hematogenix Unites With 19 Organizations from the Healthcare Community to Form COVID-19 Testing Industry Consortium
Oct 5, 2020 | Collaboration
Intermountain Healthcare Researchers Develop New Diagnostic Tool to Identify & Treat Patients with COVID-19 at Risk of Severe Illness, Death Due to Inflammatory Disorder
Oct 1, 2020 | Diagnostics
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com